SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-15
👔
Traws Pharma, Inc.
@TRAW_InsiderForm 4 Filing: Dukes Iain D. Acquires (Grant) shares of $TRAW
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Traws Pharma, Inc.
Ticker: $TRAW
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-09
Shares: 274,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Dukes Iain D., holds the title of Chief Executive Officer at Traws Pharma, Inc..
On 2026-07-09, the insider transacted 274,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Dukes Iain D. (Chief Executive Officer) was granted $0 of $TRAW
Post-Transaction Position: 274,000 shares
SEC Accession No: 0001681955-26-000002 (CIK: 1681955)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.